[1] |
张磊,刘会兰,郑昌成,等. 17例IgD型多发性骨髓瘤临床分析[J]. 临床血液学杂志,2015,28(1):12-15.
|
[2] |
LU J,LU J,CHEN W,et al.More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma:a multicenter analysis[J]. Drug Des Devel Ther,2016,10:3673-3679.
|
[3] |
KIM S J,KIM K,KIM B S,et al.Clinical features and survival outcomes in patients with multiple myeloma:analysis of web-based-data from the Korean Myeloma Registry[J]. Acta Haematol,2009,122(4):200-210.
|
[4] |
中国医师协会血液科医师分会,中华医学会血液学分会,中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2017年修订)[J]. 中华内科杂志,2017,56(11):866-870.
|
[5] |
KYLE R A,GERTZ M A,WITZIG T E,et al.Review of 1 027 patients with newly diagnosed multiple myeloma[J]. Mayo Clin Proc,2003,78(1):21-33.
|
[6] |
李昱瑛,刘晓亮,高素君,等. IgD型多发性骨髓瘤27例临床分析[J]. 中华血液学杂志,2017,38(10):893-895.
|
[7] |
ZAGOURI F,KASTRITIS E,SYMEONIDIS A S,et al.Immunoglobulin D myeloma:clinical features and outcome in the era of novel agents[J]. Eur J Haematol,2014,92(4):308-312.
|
[8] |
刘彦,克晓燕,王晶,等. IgD型多发性骨髓瘤的临床疗效分析[J]. 中国实验血液学杂志,2014,22(6):1628-1632.
|
[9] |
MITSIADES C S,MITSIADES N S,RICHARDSON P G,et al.Multiple myeloma:a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenviroment[J]. J Cell Biochem,2007,101(4):950-968.
|
[10] |
翟玉华,孙卫红,刘金英. IgD型多发性骨髓瘤免疫分型及意义[J]. 中国实验诊断学,2006,10(4):397-398.
|
[11] |
SINCLAIR D.IgD myeloma:clinical,biological and laboratory features[J]. Clin Lab,2002,48(11-12):617-622.
|
[12] |
贺婕,张慧,姜华,等. 血清IgD定量检测在IgD型多发性骨髓瘤患者疗效评估中的价值[J]. 中华血液学杂志,2016,37(4):288-291.
|
[13] |
NUCCI M,ANAISSIE E.Infections in patients with multiple myeloma[J]. Semin Hematol,2009,46(3):277-288.
|
[14] |
乔淑凯,张学军,王福旭,等. IgDλ型多发性骨髓瘤1例[J]. 中国实验血液学杂志,2007,15(3):643-646.
|
[15] |
SEKIGUCHI N,TAKEZAKO N,NAGATA A,et al.Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy[J]. Inter Med,2011,50(21):2653-2657.
|
[16] |
张守永,广圣芳. 多发性骨髓瘤32例骨髓细胞学诊断及分型[J]. 蚌埠医学院学报,2011,36(12):1391-1392.
|
[17] |
崇慧峰,孙芸,王传发,等. 免疫固定电泳和骨髓细胞形态学检查在多发性骨髓瘤临床分期中的价值比较[J]. 检验医学,2015,30(7):720-722.
|
[18] |
安然,何海燕,姜华,等. 130例IgD型多发性骨髓瘤临床特点及预后分析[J]. 临床血液学杂志,2017,30(2):194-197.
|
[19] |
PISANI F,PETRUCCI M T,GIANNARELLI D,et al.IgD multiple myeloma a descriptive report of 17 cases:survival and response to therapy[J]. J Exp Clin Cancer Res,2012,31(1):17.
|